ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpointHealth & Biotech
4 hours ago | Nadine McGrath
Positive journal publication for ImpediMed
Brisbane-based medical software technology company ImpediMed (ASX:IPD) got a lift during the week with a leading journal eClinicalMedicine, part of The Lancet Discovery Science, publishing Multinational Association of Supportive Care in Cancer (MASCC) guidelines, which specifically include bioimpedance spectroscopy (BIS) as a recommended option to identify early signs of lymphoedema.
IPD’s device the SOZO is the only FDA cleared and clinically validate BIS system for the early detection of lymphedema.
The MASCC guidance was generated by a global panel, including participants from Japan, USA, Hong Kong, Canada, Italy, Denmark, Australia, Spain and UK. IPD says the recommendations support its US and global sales efforts.
BIS for prevention of breast cancer-related lymphoedema is now included in the globally referenced NCCN Guidelines and MASCC Guidelines.
SOZO is available in the US, Australia, New Zealand, Hong Kong, UK, Ireland, Denmark and Sweden.
“It basically says from all the research that has been done one of the options is to use ImpediMed’s technology with the early detection of breast cancer-related lymphoedema,” Power says.
“That is a good piece of news and that share price has popped up a bit on the back of that because it’s really got hammered following their second quarter results which were below expectations.
“I must admit I was surprised at how far the share price got knocked but it’s clawing its way back now.”
Morgans has a speculative buy rating on IPD, reducing its 12-month target price from 22 cents to 20 cents following its Q2 Fy24 result.
- Forums
- ASX - By Stock
- IPD
- Ann: New Clinical Practice Guidance Recommends Use of BIS
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-59
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $111.2M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.5¢ | $47.99K | 858.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 513413 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 102335 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 422704 | 0.055 |
3 | 255555 | 0.054 |
4 | 330710 | 0.053 |
1 | 130000 | 0.052 |
3 | 42222 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 102335 | 1 |
0.058 | 99999 | 1 |
0.059 | 110002 | 1 |
0.060 | 41689 | 2 |
0.063 | 60166 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |